Cytogenetic methods for measuring space radiation damage in astronaut's blood lymphocytes
- 1. National Institute of Radiological Sciences, Anagawa, Chiba (Japan)
Description
A new method for chromosomal aberration dosimetry is presented here. The method is based on the induction of premature chromosome condensation in peripheral blood lymphocytes by calyculin A. When stimulated lymphocytes are incubated in calyculin A, inhibition of protein serine/threonine phosphatases induces premature chromosome condensation in the interphase chromosomes. G1, G2, and M-phase cells can be scored for chromosomal aberrations after chromosome painting. In vitro tests have been performed with cells exposed to X-rays or high-LET carbon ions. The results indicate that analysis of interphase chromosomes hybridized in situ with fluorescent probes is independent from radiation-induced cell-cycle alterations. It is also suggested that conventional metaphase analysis would not be reliable after exposure to densely ionizing radiation, when most aberrant cells are blocked in G2-phase. Advantages of this method for biodosimetry in astronauts are discussed. (author)
Additional details
Publishing Information
- Publisher
- Kodansha Scientific Ltd.
- Imprint Place
- Tokyo (Japan)
- ISBN
- 4-906464-08-4
- Imprint Title
- Risk evaluation of cosmic-ray exposure in long-term manned space mission
- Imprint Pagination
- 203 p.
- Journal Page Range
- p. 71-81
Conference
- Title
- International workshop on responses to heavy particle radiation
- Dates
- 9-10 Jul 1998
- Place
- Chiba (Japan)
INIS
- Country of Publication
- Japan
- Country of Input or Organization
- Japan
- INIS RN
- 31009115
- Subject category
- S61: RADIATION PROTECTION AND DOSIMETRY;
- Resource subtype / Literary indicator
- Conference
- Descriptors DEI
- ASTRONAUTS; BIOLOGICAL DOSEMETERS; CELL CYCLE; CHROMOSOMAL ABERRATIONS; CHROMOSOME SORTING; COSMIC RADIATION; IN VITRO; IN-SITU HYBRIDIZATION; LYMPHOCYTES; PHOSPHATASES; RADIATION HAZARDS
- Descriptors DEC
- ANIMAL CELLS; BIOLOGICAL MATERIALS; BIOTECHNOLOGY; BLOOD; BLOOD CELLS; BODY FLUIDS; CONNECTIVE TISSUE CELLS; CYTOLOGICAL TECHNIQUES; DOSEMETERS; ENZYMES; ESTERASES; GENETIC ENGINEERING; HAZARDS; HEALTH HAZARDS; HYDROLASES; IONIZING RADIATIONS; LEUKOCYTES; MATERIALS; MEASURING INSTRUMENTS; MUTATIONS; NUCLEIC ACID HYBRIDIZATION; ORGANIC COMPOUNDS; PERSONNEL; PROTEINS; RADIATIONS; SOMATIC CELLS